Author

Soeren Linnet

Observed names: Linnet, S, S. Linnet

Institution: Regionshospitalet Herning

Observed institutions: University Medical Center Groningen, University of Groningen, Regionshospitalet Herning

OpenAlex ID: A5049574284

Patients' preferences for subcutaneous trastuzumab versus conventional intravenous infusion for the adjuvant treatment of HER2-positive early breast cancer: final analysis of 488 patients in the international, randomized, two-cohort PrefHer study

2014 · X. Pivot, J. Gligorov, et al. · Annals of Oncology · 183

Liposomal cisplatin response prediction in heavily pretreated breast cancer patients: A multigene biomarker in a prospective phase 2 study.

2018 · Erik Hugger Jakobsen, Dorte Nielsen, et al. · Journal of Clinical Oncology · 8

PO-0684: Morbidity after regional nodes radiotherapy in early breast cancer patients having axillary lymph node dissection

2015 · H. Nielsen, R. Friis, et al. · Radiotherapy and Oncology · 2

Is metronomic chemotherapy less toxic than conventional chemotherapy in the randomized phase 2 XeNa trial combining navelbine oral and Xeloda for HER2 negative breast cancer patients

2015 · Anne Sofie Brems-Eskildsen, Soeren Linnet, et al. · Repositorio Institucional E-DocUR (Universidad Del Rosario) · 1

Efficacy and Toxicity of Eribulin in Real-Life Non-Selected Advanced Breast Cancer Patients

2017 · Anne Sofie Brems-Eskildsen, Kristina Bak Kristoffersen, et al. · The Breast

Retrospective-prospective blinded evaluation predicting efficacy of epirubicin by a multigene assay in advanced breast cancer within a Danish Breast Cancer Cooperative Group (DBCG) cohort.

2017 · Anna Sofie Kappel Buhl, Troels Dreier Christensen, et al. · Journal of Clinical Oncology

Prediction of exemestane benefit in patients with advanced breast cancer based on diagnostic biopsy mRNA analysis.

2017 · Troels Dreier Christensen, Anna Sofie Kappel Buhl, et al. · Journal of Clinical Oncology

Poster Abstracts

2016 · Brems-Eskildsen, A. S., Linnet, S, et al. · European Journal of Cancer

Po68 Treatment With Eribulin (halaven) in Heavily Pre-treated Patients With Metastatic Breast Cancer

2013 · M. Lynge, G.I. Liposits, et al. · The Breast

Works count: 9

Citation count: 194

H-index: 2

I10-index: 1